abstract |
The present invention describes anti-cholinergic and beta-mimetic combinations for the treatment of respiratory diseases including airway inflammation or obstruction, such as chronic obstructive pulmonary disease (COPD) and asthma. Further included is the preparation of the concomitant drug with a topical application (inhalation) and application with an inhaler, eg, Novolizer®. |